Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia

TP53 mutations are strong predictors of poor survival and refractoriness in chronic lymphocytic leukemia (CLL) and have direct implications for disease management. Clinical information on TP53 mutations is limited to lesions represented in >20% leukemic cells. Here, we tested the clinical impact...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Rossi, Davide, Khiabanian, Hossein, Spina, Valeria, Ciardullo, Carmela, Bruscaggin, Alessio, Famà, Rosella, Rasi, Silvia, Monti, Sara, Deambrogi, Clara, De Paoli, Lorenzo, Wang, Jiguang, Gattei, Valter, Guarini, Anna, Foà, Robin, Rabadan, Raul, Gaidano, Gianluca
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2014
Assuntos:
Plenary Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4017291/
https://ncbi.nlm.nih.gov/pubmed/24501221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2013-11-539726
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares